{"schemaVersion":"peptidescanner-evidence-object/v1","objectId":"story:pubmed-pmid-17595353-exenatide:v1","objectPathId":"pubmed-pmid-17595353-exenatide-v1","kind":"story-version","urls":{"story":"https://peptidescanner.com/stories/pubmed-pmid-17595353-exenatide/","json":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17595353-exenatide-v1.json","markdown":"https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-17595353-exenatide-v1.md"},"story":{"slug":"pubmed-pmid-17595353-exenatide","version":1,"domain":"Literature metadata","dateInSource":"2026-01-28","sourceCheckedAt":"2026-07-30","publishedAt":"2026-08-13","peptideSlugs":["exenatide"],"peptides":[{"slug":"exenatide","url":"https://peptidescanner.com/peptides/exenatide/"}]},"claims":[{"id":"headline","text":"Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agents.","sourceIds":["pubmed-observation-pmid-17595353-2026-01-28-5d562581ca9e"]},{"id":"summary","text":"PubMed lists PMID 17595353 in Diabetes care as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2007-06-26 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17595353-2026-01-28-5d562581ca9e"]},{"id":"paragraph-1","text":"PubMed lists PMID 17595353 in Diabetes care as Journal Article, Multicenter Study, Randomized Controlled Trial, with publication-date metadata of 2007-06-26 (day precision). PeptideScanner associated the retained record with the identity slug exenatide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.","sourceIds":["pubmed-observation-pmid-17595353-2026-01-28-5d562581ca9e"]},{"id":"paragraph-2","text":"This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth.","sourceIds":["pubmed-observation-pmid-17595353-2026-01-28-5d562581ca9e"]}],"sources":[{"id":"pubmed-observation-pmid-17595353-2026-01-28-5d562581ca9e","name":"PubMed","sourceClass":"A","title":"Exploring the substitution of exenatide for insulin in patients with type 2 diabetes treated with insulin in combination with oral antidiabetes agents. · retained source version 1:2026-01-28:current:5d562581ca9eab78233953d470dbfb092da71c9ba9f57f22f7ac561137ab867a","url":"https://pubmed.ncbi.nlm.nih.gov/17595353/"}],"correction":{"state":"none"},"boundaries":{"scope":"selected-public-evidence-only","reporting":"PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.","unknowns":["Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.","This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.","This object does not determine safety, efficacy, causality, or suitability for any person."],"methodologyUrl":"https://peptidescanner.com/methodology/","medicalDisclaimerUrl":"https://peptidescanner.com/medical-disclaimer/"},"commitments":{"publicationLedgerSha256":"ce7b4dff7a7859080689855e8187a457976e51c386b68c3aab69d3632a705c44","tierARecordSha256":"5ab510abcf51d113f12775086072e13c277d58a87da16464324ac0f8901dda7b"},"integrity":{"algorithm":"sha256","contentSha256":"7ac82f696fd0f11e9ffc2b38949723b9037ff70dd536691f6fdcce60b819c916"}}